Skottner; Anna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Skottner; Anna.The latest application filed is for "method of treating inflammation".

Company Profile

0.11.14

Skottner; Anna - Ekero SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of treating inflammation Grant 9,227,927 - Lundstedt , et al. January 5, 2	2016-01-05
Method Of Treating Inflammation App 20130295009 - LUNDSTEDT; Torbjorn ; et al.	2013-11-07
Method for treating arthritis Grant 8,410,174 - Lundstedt , et al. April 2, 2	2013-04-02
Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands Grant 8,309,609 - Lundstedt , et al. November 13, 2	2012-11-13
Method For Treating Arthritis App 20120178820 - LUNDSTEDT; Torbjorn ; et al.	2012-07-12
Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands Grant 8,148,429 - Lundstedt , et al. April 3, 2	2012-04-03
Use Of Benzylideneaminoguanidines And Hydroxyguanidines As Melanocortin Receptor Ligands App 20110015437 - Lundstedt; Torbjorn ; et al.	2011-01-20
N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands App 20090018183 - Lundstedt; Torbjorn ; et al.	2009-01-15
Methods and Pharmaceutical Compositions for the Treatment of Neurological Damage App 20080275129 - Lundstedt; Torbjorn ; et al.	2008-11-06
N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands Grant 7,442,807 - Lundstedt , et al. October 28, 2	2008-10-28
Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands App 20070231267 - Lundstedt; Torbjorn ; et al.	2007-10-04
Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands App 20070088085 - Lundstedt; Torbjorn ; et al.	2007-04-19
N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands Grant 7,186,748 - Lundstedt , et al. March 6, 2	2007-03-06
Compounds acting as melanocortin receptor ligands Grant 7,153,881 - Lundstedt , et al. December 26, 2	2006-12-26
N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands App 20060148798 - Lundstedt; Torbjorn ; et al.	2006-07-06
N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands App 20040254093 - Lundstedt, Torbjorn ; et al.	2004-12-16
Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors App 20040106682 - Lundstedt, Torbjorn ; et al.	2004-06-03
Uses of benzylideneamino guanidines as ligands to the melnocortin receptors App 20040106683 - Lundstedt, Torbjorn ; et al.	2004-06-03
Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands App 20040024060 - Lundstedt, Torbjorn ; et al.	2004-02-05
Compounds acting as melanocortin receptor ligands App 20040019094 - Lundstedt, Torbjorn ; et al.	2004-01-29
Novel melanocortin receptor agonists and antagonists App 20030195212 - Lundstedt, Torbjorn ; et al.	2003-10-16
Use of insulin and IGF-I Grant 5,994,303 - Arrhenius-Nyberg , et al. November 30, 1	1999-11-30
Use of human IGF-1 to treat cardiac disorders Grant 5,434,134 - Gluckman , et al. July 18, 1	1995-07-18
Method of improving regeneration of transfected peripheral nerves using IGF-1 Grant 5,068,224 - Fryklund , et al. November 26, 1	1991-11-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.